✦ LIBER ✦

454 PREDICTORS OF HEPATITIS B VIRUS RECURRENCE WITH EMERGENCE OF YMDD MOTIF MUTANT FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION

✍ Scribed by J. Chun; W. Kim; J.H. Kim; M.S. Kwak; S.W. Hwang; Y.J. Jung; J.B. Jeong; B.G. Kim; K.L. Lee; D.H. Kim; K.-S. Suh; N.-J. Yi; Y.J. Kim; J.-H. Yoon; H.S. Lee

Book ID: 117377463
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 66 KB
Volume: 50
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(09)60456-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Favorable outcome of orthotopic liver tr

Favorable outcome of orthotopic liver transplantation in a patient with subacute liver failure due to the emergence of a hepatitis B YMDD escape mutant virus

✍ Peter Stärkel; Yves Horsmans; André Geubel; Olga Ciccarelli; Patrick Goubau; Jac 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Clearance of the original hepatitis B vi

Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy

✍ Chau-Ting Yeh; Rong-Nan Chien; Chia-Ming Chu; Yun-Fan Liaw 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB

(160) Predictors of responses to adefovi

(160) Predictors of responses to adefovir therapy in patients with lamivudine-resistant hepatitis B virus YMDD mutant before and after liver transplantation

✍ Ahmed Helmy; Ayman. Abdo; Hatim Mudawi; Khalid Al-Kahtani; Hamad Al-Ashgar; Moha 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 41 KB

Initial viral response is the most power

Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine

✍ Nao Kurashige; Naoki Hiramatsu; Kazuyoshi Ohkawa; Tsugiko Oze; Yuko Inoue; Mika 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Subcutaneous administration of hepatitis

Subcutaneous administration of hepatitis B immune globulin in combination with lamivudine following orthotopic liver transplantation: effective prophylaxis against recurrence

✍ James J. Powell; Wichian Apiratpracha; Nilufar Partovi; Siegfried R. Erb; Charle 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Clinical Outcomes and Risk Factors of He

Clinical Outcomes and Risk Factors of Hepatitis B Virus Recurrence in Patients Who Received Prophylaxis With Entecavir and Hepatitis B Immunoglobulin Following Liver Transplantation

✍ Kim, Y.-K.; Kim, S.H.; Lee, S.D.; Park, S.-J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 212 KB